scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.1007/S10038-007-0189-3 |
P698 | PubMed publication ID | 17805475 |
P50 | author | Elias Zintzaras | Q100468642 |
P2093 | author name string | Ioannis Stefanidis | |
Afroditi A Papathanasiou | |||
Katrin Uhlig | |||
George N Koukoulis | |||
P2860 | cites work | Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis | Q52967308 |
Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis | Q53005037 | ||
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy | Q53010730 | ||
Language bias in randomised controlled trials published in English and German | Q53358085 | ||
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease | Q57268055 | ||
Homocysteine and vascular disease | Q70992813 | ||
The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients | Q73030991 | ||
Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients | Q73176797 | ||
Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients | Q73184742 | ||
No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy | Q73676311 | ||
Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? | Q74532281 | ||
MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes | Q77345813 | ||
A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy | Q77762900 | ||
Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis | Q80184660 | ||
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice | Q80305250 | ||
Heterogeneity testing in meta-analysis of genome searches | Q81128804 | ||
HEGESMA: genome search meta-analysis and heterogeneity testing | Q81849916 | ||
Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis | Q83185623 | ||
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 | ||
Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
Meta-analysis in clinical trials | Q27860779 | ||
Extreme between-study homogeneity in meta-analyses could offer useful insights | Q33257829 | ||
Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification | Q34323060 | ||
Diabetic nephropathy: diagnosis, prevention, and treatment | Q34379284 | ||
Epidemiological methods for studying genes and environmental factors in complex diseases | Q34421625 | ||
The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis | Q34452277 | ||
Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations | Q35196472 | ||
Sleep-disordered breathing and blood pressure in children: a meta-analysis | Q36729397 | ||
BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis | Q37365226 | ||
MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients | Q39277778 | ||
Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. | Q40595070 | ||
Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. | Q40637417 | ||
Is diabetic nephropathy an inherited complication? | Q41109741 | ||
Cumulative meta-analysis of therapeutic trials for myocardial infarction | Q41112231 | ||
Familial factors determine the development of diabetic nephropathy in patients with IDDM. | Q41152952 | ||
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. | Q41576959 | ||
Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour | Q43674164 | ||
Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. | Q44152307 | ||
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. | Q44191190 | ||
Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes | Q44459456 | ||
Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy | Q44535803 | ||
Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up | Q44557306 | ||
The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. | Q44737441 | ||
Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients | Q44882753 | ||
Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients | Q45022762 | ||
C677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemia | Q45138816 | ||
Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis | Q45245187 | ||
The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis | Q46497844 | ||
Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? | Q46914188 | ||
Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients | Q47670854 | ||
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? | Q47854203 | ||
Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis | Q48214700 | ||
Nephropathy of type II diabetes: evidence for hereditary factors? | Q50955890 | ||
C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies | Q51805701 | ||
A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia | Q51935792 | ||
P433 | issue | 11 | |
P921 | main subject | meta-analysis | Q815382 |
diabetic nephropathy | Q1129105 | ||
P304 | page(s) | 881-890 | |
P577 | publication date | 2007-09-06 | |
P1433 | published in | Journal of Human Genetics | Q6295302 |
P1476 | title | Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis | |
P478 | volume | 52 |
Q44513343 | An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy |
Q34191574 | Association Between theMTHFRGene and Alzheimer's Disease: A Meta-Analysis |
Q53087421 | Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects |
Q38905451 | Genetic Susceptibility to Type 2 Diabetes: A Global Meta-Analysis Studying the Genetic Differences in Tunisian Populations |
Q58610896 | Interaction of MTHFR C677T polymorphism with smoking in susceptibility to diabetic nephropathy in Chinese men with type 2 diabetes |
Q62071574 | Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients |
Q38061783 | MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: A meta-analysis |
Q46952683 | Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis |
Q57788997 | The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis |
Q45131094 | The role of MTHFR gene in multiple myeloma |
Q80176879 | Trends in meta-analysis of genetic association studies |
Search more.